Table 2.
Individual EEG characteristics and clinical manifestations of 37 patients with sCJD.
| No. | Gender | Age (year) | Time of first EEG examination post-onset (weeks) | Initial symptom | Basic rhythm of EEG (Hz) | Background activity grades | PSWC | Main discharge area (general classification) | 1,433 protein of CSF | Survival time (months) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Female | 66 | 1 | Speech disorder | 4–7 | Moderate | Typical | Frontal area | Positive | NA |
| 2 | Male | 45 | 2 | Sluggishness | 8.5–10 | Mild | Atypical | Frontal area | Positive | 2 |
| 3 | Male | 64 | 40 | Memory impairment | 2–6 | Severe | Typical | Central-Parietal area | NA | 1 |
| 4 | Female | 60 | 32 | Memory impairment | 2–6 | Severe | Typical | Frontal area | NA | NA |
| 5 | Male | 57 | 24 | Memory impairment | 2–6 | Severe | Typical | Frontal area | NA | 12 |
| 6 | Female | 57 | 4 | Motor disorder | 1.5–3 | Severe | Typical | Frontal-Central-Parietal area | Positive | 2 |
| 7 | Female | 58 | 1.5 | Motor disorder | 1.5–3.5 | Severe | Typical | Parietal area | Positive | 6 |
| 8 | Female | 57 | 3 | Motor disorder | 2–6 | Severe | Typical | Frontal area | Positive | 12 |
| 9 | Female | 69 | 8 | Sluggishness | 4–7 | Severe | Typical | Occipital area | Negative | 1.5 |
| 10 | Male | 51 | 12 | Motor disorder | 4–7 | Moderate | Typical | Central-Parietal area | NA | 0.5 |
| 11 | Female | 60 | 3 | Motor disorder | 8–11 | Mild | Atypical | Frontal area | NA | 1 |
| Male | 66 | 12 | Sluggishness | 4–7 | Moderate | Typical | Temporal area | Positive | 45 | |
| 13 | Female | 64 | 3 | Psychotic behavioral abnormalities | 1–3.5 | Severe | Typical | Frontal area | Positive | 15 |
| 14 | Male | 33 | 8 | Speech disorder | 1–3.5 | Severe | Typical | Frontal area | Positive | 36 |
| 15 | Female | 54 | 2.5 | Memory impairment | 1.5–3.5 | Severe | Typical | Frontal area | Negative | 3 |
| 16 | Male | 68 | 12 | Sluggishness | 4–7 | Moderate | Typical | Full lead | Positive | 1 |
| 17 | Male | 83 | 6 | Dizziness | 3–7 | Moderate | Typical | Central-Parietal area | Negative | 13 |
| 18 | Male | 67 | 4 | Sluggishness | 4–7 | Severe | Typical | Full lead | Positive | 2.5 |
| 19 | Female | 69 | 2 | Speech disorder | 4–7 | Moderate | Typical | Full lead | Negative | 6 |
| 20 | Male | 58 | 4 | Dizziness | 1.5–7 | Moderate | Typical | Frontal area | Positive | 24 |
| 21 | Male | 54 | 8 | Memory impairment | 4–7 | Moderate | Typical | Frontal area | Positive | alive |
| 22 | Male | 60 | 1 | Memory impairment | 4–7 | Moderate | Typical | Frontal area | Positive | 1.5 |
| 23 | Male | 80 | 1 | Sluggishness | 1.5–3.5 | Severe | Typical | Frontal area | Positive | 0.75 |
| 24 | Female | 49 | 4 | Visual disturbance | 4–7 | Moderate | Typical | Occipital area | Positive | 2 |
| 25 | Female | 39 | 8 | Dizziness | 4–7 | Moderate | Typical | Frontal area | Positive | 3.5 |
| 26 | Female | 68 | 8 | Speech disorder | 1.5–7 | Moderate | Atypical | Temporal area | Positive | 12 |
| 27 | Male | 72 | 28 | Sluggishness | 6.5–8.5 | Mild | Atypical | Frontal-Temporal area | Negative | 5 |
| 28 | Female | 70 | 6 | Dizziness | 1.5–3.5 | Severe | Atypical | Occipital area | Positive | 0.25 |
| 29 | Female | 69 | 3 | Memory impairment | 4–7 | Severe | Typical | Parietal–Temporal area | Positive | dieda |
| 30 | Male | 90 | 24 | Dizziness | 7–9 | Mild | Typical | Frontal-Temporal area | NA | dieda |
| 31 | Female | 58 | 4 | Memory impairment | 4–7 | Moderate | Typical | Full lead | NA | NA |
| 32 | Female | 69 | 6 | Dizziness | 4–7 | Moderate | Typical | Frontal area | Positive | 0.75 |
| 33 | Male | 75 | 6 | Memory impairment | 1.5–3.5 | Severe | Typical | Full lead | Positive | 8 |
| 34 | Female | 64 | 24 | Motor disorder | 4–7 | Moderate | Typical | Frontal area | Positive | 1 |
| 35 | Female | 58 | 6 | Motor disorder | 1.5–5 | Severe | Typical | Central-Parietal area | Positive | 26 |
| 36 | Male | 77 | 4 | Motor disorder | 1.5–3.5 | Severe | Atypical | Frontal area | Positive | 3.5 |
| 37 | Female | 75 | 8 | Memory impairment | 2.5–4 | Severe | Typical | Full lead | Negative | 3 |
aDeath time was none available.
EEG, Electroencephalography; NA, none available; PSWC, periodic sharp wave complexes; sCJD, sporadic Creutzfeldt-Jakob disease.